Vineet Laboratories Share Price

₹ 36.09

-₹1.83 (-4.83%)

Last updated 02 Nov, 2026, 15:56 IST

NSE: VINEETLAB

Vineet Laboratories Share Price Today

As of 3 Nov 2026, Vineet Laboratories share price is ₹36.09. The stock opened at ₹38.40, compared to its previous close of ₹37.92. During today's trading session, Vineet Laboratories share price moved in the range of ₹35.64 to ₹38.50, with an average price of ₹37.07 for the day. Looking at its last 52-week, the stock has touched a low of ₹27.96 and a high of ₹49.44. On the performance front, Vineet Laboratories share price has declined by 5.18% over the last six months and is down 22.39% on a year-on-year basis.

₹35.64

4.83% down today

₹38.50

1D LOW

1D HIGH

Vineet Laboratories Stock Insights

Stock Performance

OutperformingBeat Nifty by 0.14 % in last 1 month

Shareholding Pattern

FIIFII decreased stake by 51.45%

Vineet Laboratories Stock Insights

Stock Performance

OutperformingBeat Nifty by 0.14 % in last 1 month

Shareholding Pattern

FIIFII decreased stake by 51.45%

Vineet Laboratories stock performance
Open	₹38.40
High	₹38.50
Low	₹35.64
Prev. close	₹37.92

Vineet Laboratories trading activity
Volume	91,189
Average traded price	₹36.98
Last traded time	03:56:12 02 Nov
Last traded quantity	100

₹32.49₹39.69

Circuit Low

Circuit High

₹27.96₹49.44

52-Week Low

52-Week High

Circuit

₹32.49

₹39.69

52-week

₹27.96

₹49.44

Mkt Cap Cr

69.62

P/E

19.92

P/B

1.53

ROA

2.8%

ROE

2.44%

ROCE

6.78%

EV/EBITDA

9.54

Mkt Cap Cr

69.62

P/E

19.92

P/B

1.53

ROA

2.8%

ROE

2.44%

ROCE

6.78%

EV/EBITDA

9.54

Based on fundamentals, this stock's

Performance

Excellent

Vineet Laborator outperforming all market indices

Valuation

Overvalued

Vineet Laborator appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vineet Laboratories Company Background

ISIN

INE505Y01010

Sector Market Cap

₹ 69.62 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Vineet Laboratories Financial Highlights

Revenue: Vineet Laboratories reported revenue of ₹59.50 crore in FY26 vs ₹76.99 crore in FY25. It showed a decrease of 22.72% on a yearly basis.
Operating Profit: Vineet Laboratories reported an operating profit of ₹1.28 crore in FY26 vs ₹20.78 crore in FY25. It showed an increase of 106.16% on a year-on-year basis.
Net Profit: Vineet Laboratories reported a net profit of ₹1.11 crore in FY26 vs ₹20.19 crore in FY25. It showed an increase of 105.50% on a yearly basis.

Vineet Laboratories Quarterly Result Highlights

Vineet Laboratories reported revenue of ₹10.50 crore in Jun 2026, compared with ₹18.92 crore in Mar 2026, representing a decrease of 44.50% on a quarter-on-quarter (QoQ) basis.
Vineet Laboratories reported an operating profit of ₹0.79 crore in Jun 2026, compared with ₹0.99 crore in Mar 2026, representing a decrease of 20.20% on a quarter-on-quarter (QoQ) basis.
Vineet Laboratories reported a profit of ₹1.51 crore in Jun 2026, compared with ₹0.73 crore in Mar 2026, reflecting an increase of 106.85% on a QoQ basis.
The earnings per share (EPS) of Vineet Laboratories stood at ₹21.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

5.98%

FII

0.24%

Other DII

0.00%

Retail and other

93.78%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Feb 2026	0.00%
Mar 2026	0.36%
Jun 2026	0.50%
Sep 2026	0.24%

Vineet Laboratories Investment Returns

1 day

-4.83%

1 week

-3.37%

1 month

+0.50%

1 year

-22.39%

3 years

-32.98%

5 years

-55.91%

Vineet Laboratories Share Price History

Vineet Laboratories share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹38.40 / ₹36.09	-4.83%
30 Oct 26	₹37.11 / ₹37.92	+0.42%
29 Oct 26	₹36.60 / ₹37.76	+4.71%
28 Oct 26	₹37.30 / ₹36.06	-1.98%
27 Oct 26	₹37.98 / ₹36.79	-1.50%
26 Oct 26	₹35.62 / ₹37.35	+3.09%
23 Oct 26	₹38.40 / ₹36.23	-2.58%
22 Oct 26	₹38.99 / ₹37.19	-2.18%
21 Oct 26	₹39.10 / ₹38.02	-1.76%
19 Oct 26	₹39.60 / ₹38.70	-0.79%

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹75.00	₹150.59	₹212.29	₹191.17
Other Income	₹1.99	₹0.46	₹0.12	₹0.29
Total Revenue	₹76.98	₹151.05	₹212.42	₹191.46
Total Expenses	₹97.76	₹150.69	₹210.39	₹182.11
Profit Before Tax	-₹20.78	₹0.36	₹2.03	₹9.35
Tax	-₹0.58	-₹0.66	₹0.78	₹2.71
Profit After Tax	-₹20.19	₹1.03	₹1.25	₹6.64
EPS - Basic	-₹21.90	₹1.11	₹1.36	₹7.16
EPS - Diluted	-₹21.90	₹1.11	₹1.36	₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹20.78	₹0.36	₹2.03	₹9.35
Income before WC changes	-₹12.34	₹7.15	₹8.00	₹13.25
Change in Assets	₹21.13	-₹1.21	₹5.87	-₹7.16
Change in Liabilities	₹2.82	-₹12.29	-₹20.50	₹4.72
Change in WC	₹23.95	-₹13.50	-₹14.63	-₹2.43
Cash flow from Operations	₹11.49	-₹6.61	-₹9.62	₹7.63
Cash flow from Investing	-₹3.18	-₹2.22	-₹6.69	-₹3.68
Cash flow from Financing	-₹8.23	₹8.43	₹0.27	₹11.96
Total Cash Flow	₹0.08	-₹0.40	-₹16.03	₹15.91
Cash (Start of the year)	₹0.23	₹0.63	₹16.66	₹0.75
Cash (End of the year)	₹0.31	₹0.23	₹0.63	₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹27.15	₹28.68	₹28.39	₹30.61
Current Assets	₹67.39	₹88.19	₹87.46	₹102.70
Total Assets	₹94.54	₹116.87	₹115.85	₹133.32
Current Liabilities	₹74.39	₹76.00	₹74.51	₹94.77
Net Current Asset	-₹7.00	₹12.19	₹12.95	₹7.94
Non-Current Liabilities	₹5.50	₹6.15	₹7.66	₹5.33
Equity Capital	₹14.65	₹34.72	₹33.68	₹33.22
Total Equity & Liabilities	₹94.54	₹116.87	₹115.85	₹133.32